Ra Medical Systems, Inc.
RMED · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $226 | $212 | $143 | $93 |
| % Growth | 6.6% | 48.3% | 53.8% | – |
| Cost of Goods Sold | $18 | $14 | $11 | $6 |
| Gross Profit | $208 | $198 | $132 | $87 |
| % Margin | 92% | 93.4% | 92.3% | 93.5% |
| R&D Expenses | $276 | $155 | $103 | $214 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,953 | $2,881 | $3,485 | $3,044 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1,834 | $108 | $0 |
| Operating Expenses | $3,229 | $4,870 | $3,696 | $3,258 |
| Operating Income | -$3,021 | -$4,672 | -$3,564 | -$47,907 |
| % Margin | -1,336.7% | -2,203.8% | -2,492.3% | -51,512.9% |
| Other Income/Exp. Net | $755 | -$1,736 | -$1,205 | $104,308 |
| Pre-Tax Income | -$2,266 | -$6,408 | -$4,769 | $56,401 |
| Tax Expense | -$78 | -$1,299 | -$724 | $2,341 |
| Net Income | -$2,251 | -$5,109 | -$4,045 | $48,902 |
| % Margin | -996% | -2,409.9% | -2,828.7% | 52,582.8% |
| EPS | -1.7 | -0.38 | -0.36 | 18.54 |
| % Growth | -347.4% | -5.6% | -101.9% | – |
| EPS Diluted | -1.7 | -0.38 | -0.36 | 18.54 |
| Weighted Avg Shares Out | 13,206 | 13,336 | 11,284 | 3,264 |
| Weighted Avg Shares Out Dil | 13,206 | 13,336 | 11,284 | 3,264 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $3 | $18 | -$194 |
| Interest Expense | $35 | $67 | $49 | -$91 |
| Depreciation & Amortization | $528 | $0 | $0 | -$1,526 |
| EBITDA | -$1,703 | -$4,672 | -$3,564 | $49,626 |
| % Margin | -753.5% | -2,203.8% | -2,492.3% | 53,360.8% |